Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.75 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.63 |
| ▸ | HPGD | P15428 | 9/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | PKM | P14618 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.51 |
| ▸ | POLB | P06746 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31574337 | 0.92 | RAB9A (0.66) | RAB9ASMN1; SMN2HPGDALDH1A1LMNA | |
| SCHEMBL6013184 | 0.90 | RAB9A (0.64) | RAB9ASMN1; SMN2HPGDALDH1A1LMNA | |
| SCHEMBL8088101 | 0.90 | RAB9A (0.64) | RAB9ASMN1; SMN2HPGDALDH1A1LMNA | |
| SCHEMBL7110355 | 0.88 | HPGD (0.67) | RAB9ASMN1; SMN2HPGDALDH1A1LMNA | |
| SCHEMBL2385213 | 0.86 | HPGD (0.76) | RAB9ASMN1; SMN2HPGDALDH1A1LMNA | |
| SCHEMBL16263501 | 0.86 | RAB9A (0.64) | RAB9ASMN1; SMN2HPGDALDH1A1LMNA | |
| SCHEMBL16263520 | 0.86 | RAB9A (0.64) | RAB9ASMN1; SMN2HPGDALDH1A1LMNA | |
| SCHEMBL17152696 | 0.84 | RAB9A (0.57) | RAB9ASMN1; SMN2HPGDALDH1A1LMNA | |
| SCHEMBL7047963 | 0.84 | RAB9A (0.57) | RAB9ASMN1; SMN2ALDH1A1LMNAPKM | |
| SCHEMBL6013323 | 0.84 | RAB9A (0.57) | RAB9ASMN1; SMN2HPGDALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11814527-B2 | Three-dimensional printing with supramolecular templated hydrogels | TRUSTEES OF DARTMOUTH COLLEGE (US) | 2023-11-14 | — | — | US | disclosed |
| US-11814527-B2 | Three-dimensional printing with supramolecular templated hydrogels | TRUSTEES OF DARTMOUTH COLLEGE (US) | 2023-11-14 | — | — | US | disclosed |
| US-20200131383-A1 | THREE-DIMENSIONAL PRINTING WITH SUPRAMOLECULAR TEMPLATED HYDROGELS | TRUSTEES OF DARTMOUTH COLLEGE (US) | 2020-04-30 | — | — | US | disclosed |
| US-20040010028-A1 | Self-assembled nanostructures with macroscopic polar order | TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE | 2004-01-15 | — | — | US | disclosed |
| WO-2002044124-A9 | SELF-ASSEMBLED NANOSTRUCTURES WITH MACROSCOPIC POLAR ORDER | UNIV COLUMBIA (US) | 2003-11-13 | — | — | WO | disclosed |
| WO-2002044124-A2 | SELF-ASSEMBLED NANOSTRUCTURES WITH MACROSCOPIC POLAR ORDER | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2002-06-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040010028-A1 | Self-assembled nanostructures with macroscopic polar order | PIEZO1, PYM1, KCNH1 | RAB9A 2310/4885SMN1; SMN2 3585/4885HPGD 4670/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.